XML 33 R19.htm IDEA: XBRL DOCUMENT
v3.20.4

Supplemental Balance Sheet Information | 12 Months Ended
--- | ---
Dec. 31, 2020
Accounts Payable and Accrued Liabilities, Current [Abstract] |
Supplemental Balance Sheet Information | Supplemental Balance Sheet Information Accrued expenses reflected within current liabilities on the Company’s consolidated balance sheets consist of the following:
| As of December 31,
(in thousands) | 2020 |  | 2019
Salaries and wages | $ | 65,310 |  |  | $ | 86,476 |
Insurance reserves | 64,633 |  |  | 63,230 |
Paid time off | 37,848 |  |  | 37,415 |
Deferred payroll taxes (Note 3) | 36,336 |  |  | — |
Real estate taxes | 25,495 |  |  | 25,979 |
Interest | 11,453 |  |  | 16,196 |
Accrued utilities | 7,507 |  |  | 7,601 |
Taxes payable | 3,806 |  |  | 1,360 |
Other | 35,463 |  |  | 28,446 |
Total | $ | 287,851 |  |  | $ | 266,703 |
Other assets, net reflected on the Company's consolidated balance sheets consist of the following:
| As of December 31,
(in thousands) | 2020 |  | 2019
Health care licenses(1) | $ | 34,060 |  |  | $ | 35,198 |
Lease security deposit | 3,180 |  |  | 49,102 |
Other | 19,019 |  |  | 34,431 |
Total | $ | 56,259 |  |  | $ | 118,731 |
(1) Health care licenses are indefinite-lived intangible assets and are not subject to amortization. Investment in Unconsolidated VenturesAs of December 31, 2019, the Company held a 51% equity interest, and Healthpeak owned a 49% interest, in the CCRC Venture, which owned and operated 16 entry fee CCRCs. The Company's ownership interests in the CCRC Venture were accounted for under the equity method of accounting. Refer to Note 4 for information on the Company's sale of the equity interest in the CCRC Venture on January 31, 2020 and movement of the remaining two entry fee CCRCs into a new unconsolidated venture. As a result of the recognition of the Company’s investment basis at the carrying amounts of the net assets contributed upon formation of the CCRC Venture and subsequent cash distributions, the Company's carrying amount of its equity method investment in the CCRC Venture property company was reduced below zero and the Company had recorded a $66.2 million equity method liability within other liabilities within the consolidated balance sheet as of December 31, 2019. As of December 31, 2020, other liabilities within the consolidated balance sheet included a $10.1 million equity method liability for the new unconsolidated venture which owns the remaining two entry fee CCRCs.

X
- References No definition available. + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration